
Provides important key prevalence and risk take aways available in DSE-00932 JUN 2022, the Aresta Reprint “When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis”. A copy of DSE-00932 JUN 2022, the Aresta Reprint, will be provided within each carrier
FIELD USE:
- PRINT: Discuss & Leave Behind
- DIGITAL: May not be shared digitally
- MAIL: Can be mailed to HCP office. Must include Disease Mailing Resource Letter (DSE-00738 AUG 2020) with mailing